The Center for Immunization Research is studying an intravenous medication called AV-1 to see whether it can prevent dengue infection if given prior to exposure to the virus or can be used to treat the disease after such exposure
Participants will make four annual in-person visits to the lab for cognitive assessments, a blood draw, and an MRI scan, and they will complete four short online surveys over the course of the study
The program, which supports innovative community-led initiatives to reduce violence in Baltimore, has announced a second round of funding for local organizations. Applications will be accepted through Feb. 10, 2025.